Josh Hansen

Title: Innovations by Josh Hansen

Introduction

Josh Hansen is an accomplished inventor based in Longmont, CO (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that inhibit Raf kinase. With a total of 2 patents, Hansen's work is pivotal in addressing various disorders mediated by this kinase.

Latest Patents

Hansen's latest patents include "Imidazopyrazines as Raf inhibitor compounds." This patent describes compounds of Formula I that are useful for inhibiting Raf kinase and for treating disorders mediated thereby. The methods disclosed involve using these compounds, along with their stereoisomers, tautomers, solvates, and pharmaceutically acceptable salts, for in vitro, in situ, and in vivo diagnosis, prevention, or treatment of such disorders in mammalian cells.

Another notable patent is "RAF inhibitor compounds and methods." This patent focuses on pyrazolyl compounds of Formulas Ia and Ib, which are also useful for inhibiting Raf kinase. The methods outlined in this patent similarly cover the use of these pyrazolyl compounds for in vitro, in situ, and in vivo diagnosis, prevention, or treatment of associated pathological conditions.

Career Highlights

Throughout his career, Hansen has worked with prominent companies in the biopharmaceutical industry. He has been associated with Array Biopharma Inc. and Genentech, Inc., where he has contributed to innovative research and development efforts.

Collaborations

Hansen has collaborated with notable professionals in his field, including Ellen Ruth Laird and Joseph P. Lyssikatos. These collaborations have further enhanced his research and development capabilities.

Conclusion

Josh Hansen's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the treatment of disorders mediated by Raf kinase, showcasing the importance of innovation in healthcare.